Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice

The MILIS-TIMI experience

Jorge Kizer, Christopher P. Cannon, Carolyn H. McCabe, Hiltrud S. Mueller, Marc J. Schweiger, Vicki G. Davis, Rebecca Perritt, Elliott M. Antman

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Although studies have documented that randomized, controlled trials (RCTs) have a measurable influence on clinical practice, investigators have uncovered important deficiencies in the application of RCT findings to the management of acute myocardial infarction (AMI). Little is known about the extent to which physicians who design and/or implement clinical trials differ from physicians in routine practice in their translation of the literature. Methods: Our aims were to (1) evaluate recent trends in selected treatments of AMI in relation to the publication of RCTs, statistical overviews, and task-force guidelines, and (2) compare prescribing practices in AMI management between physicians in routine clinical practice and physicians who design and/or implement RCTs. We reviewed the use of aspirin, β-blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers on entry and at discharge n patients enrolled in the MILIS, TIM 1, 2, 4, 5, 6, and 9B trials with ST-elevation (and depression in MILIS) myocardial infarction for a period approaching 2 decades (August 1978 to September 1995). We hypothesized that physicians who participate in RCTs apply the findings of the published literature more promptly and thoroughly than physicians in routine practice. Results: Use of aspirin, β-blockers, and angiotensin converting enzyme inhibitors exhibited a statistically significant time-related increase at discharge and, excepting β-blockers, at enrollment across the trials. Prescription of calcium channel blockers showed a statistically significant decrease at discharge only. For all medications under study, increases and earlier and more decreases in use associated with publication of clinical data occurred earlier and more steeply for the discharge cohort (prescriptions by physicians participating in RCTs) than for the enrollment cohort (prescriptions by physicians in routine practice). Recent prescribing practices (1994 to 1995) among RCT investigators and their colleagues have higher concordance with published findings than those of physicians in routine practice. Conclusions: Physicians who design and/or implement RCTs translate the results of the medical literature more promptly and to a greater extent than physicians in routine clinical practice. Differences between different physician classes need to be studied further amid efforts to reconfigure health care delivery that currently favor more dominant roles for primary care physicians.

Original languageEnglish (US)
Pages (from-to)79-92
Number of pages14
JournalAmerican Heart Journal
Volume137
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Myocardial Infarction
Physicians
Drug Therapy
Randomized Controlled Trials
Prescriptions
Calcium Channel Blockers
Angiotensin-Converting Enzyme Inhibitors
Aspirin
Publications
Research Personnel
Patient Discharge
Primary Care Physicians
Advisory Committees
Clinical Trials
Guidelines
Delivery of Health Care

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice : The MILIS-TIMI experience. / Kizer, Jorge; Cannon, Christopher P.; McCabe, Carolyn H.; Mueller, Hiltrud S.; Schweiger, Marc J.; Davis, Vicki G.; Perritt, Rebecca; Antman, Elliott M.

In: American Heart Journal, Vol. 137, No. 1, 1999, p. 79-92.

Research output: Contribution to journalArticle

Kizer, Jorge ; Cannon, Christopher P. ; McCabe, Carolyn H. ; Mueller, Hiltrud S. ; Schweiger, Marc J. ; Davis, Vicki G. ; Perritt, Rebecca ; Antman, Elliott M. / Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice : The MILIS-TIMI experience. In: American Heart Journal. 1999 ; Vol. 137, No. 1. pp. 79-92.
@article{a7a60b0afa574effae8d8002d0889700,
title = "Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: The MILIS-TIMI experience",
abstract = "Background: Although studies have documented that randomized, controlled trials (RCTs) have a measurable influence on clinical practice, investigators have uncovered important deficiencies in the application of RCT findings to the management of acute myocardial infarction (AMI). Little is known about the extent to which physicians who design and/or implement clinical trials differ from physicians in routine practice in their translation of the literature. Methods: Our aims were to (1) evaluate recent trends in selected treatments of AMI in relation to the publication of RCTs, statistical overviews, and task-force guidelines, and (2) compare prescribing practices in AMI management between physicians in routine clinical practice and physicians who design and/or implement RCTs. We reviewed the use of aspirin, β-blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers on entry and at discharge n patients enrolled in the MILIS, TIM 1, 2, 4, 5, 6, and 9B trials with ST-elevation (and depression in MILIS) myocardial infarction for a period approaching 2 decades (August 1978 to September 1995). We hypothesized that physicians who participate in RCTs apply the findings of the published literature more promptly and thoroughly than physicians in routine practice. Results: Use of aspirin, β-blockers, and angiotensin converting enzyme inhibitors exhibited a statistically significant time-related increase at discharge and, excepting β-blockers, at enrollment across the trials. Prescription of calcium channel blockers showed a statistically significant decrease at discharge only. For all medications under study, increases and earlier and more decreases in use associated with publication of clinical data occurred earlier and more steeply for the discharge cohort (prescriptions by physicians participating in RCTs) than for the enrollment cohort (prescriptions by physicians in routine practice). Recent prescribing practices (1994 to 1995) among RCT investigators and their colleagues have higher concordance with published findings than those of physicians in routine practice. Conclusions: Physicians who design and/or implement RCTs translate the results of the medical literature more promptly and to a greater extent than physicians in routine clinical practice. Differences between different physician classes need to be studied further amid efforts to reconfigure health care delivery that currently favor more dominant roles for primary care physicians.",
author = "Jorge Kizer and Cannon, {Christopher P.} and McCabe, {Carolyn H.} and Mueller, {Hiltrud S.} and Schweiger, {Marc J.} and Davis, {Vicki G.} and Rebecca Perritt and Antman, {Elliott M.}",
year = "1999",
doi = "10.1016/S0002-8703(99)70462-X",
language = "English (US)",
volume = "137",
pages = "79--92",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice

T2 - The MILIS-TIMI experience

AU - Kizer, Jorge

AU - Cannon, Christopher P.

AU - McCabe, Carolyn H.

AU - Mueller, Hiltrud S.

AU - Schweiger, Marc J.

AU - Davis, Vicki G.

AU - Perritt, Rebecca

AU - Antman, Elliott M.

PY - 1999

Y1 - 1999

N2 - Background: Although studies have documented that randomized, controlled trials (RCTs) have a measurable influence on clinical practice, investigators have uncovered important deficiencies in the application of RCT findings to the management of acute myocardial infarction (AMI). Little is known about the extent to which physicians who design and/or implement clinical trials differ from physicians in routine practice in their translation of the literature. Methods: Our aims were to (1) evaluate recent trends in selected treatments of AMI in relation to the publication of RCTs, statistical overviews, and task-force guidelines, and (2) compare prescribing practices in AMI management between physicians in routine clinical practice and physicians who design and/or implement RCTs. We reviewed the use of aspirin, β-blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers on entry and at discharge n patients enrolled in the MILIS, TIM 1, 2, 4, 5, 6, and 9B trials with ST-elevation (and depression in MILIS) myocardial infarction for a period approaching 2 decades (August 1978 to September 1995). We hypothesized that physicians who participate in RCTs apply the findings of the published literature more promptly and thoroughly than physicians in routine practice. Results: Use of aspirin, β-blockers, and angiotensin converting enzyme inhibitors exhibited a statistically significant time-related increase at discharge and, excepting β-blockers, at enrollment across the trials. Prescription of calcium channel blockers showed a statistically significant decrease at discharge only. For all medications under study, increases and earlier and more decreases in use associated with publication of clinical data occurred earlier and more steeply for the discharge cohort (prescriptions by physicians participating in RCTs) than for the enrollment cohort (prescriptions by physicians in routine practice). Recent prescribing practices (1994 to 1995) among RCT investigators and their colleagues have higher concordance with published findings than those of physicians in routine practice. Conclusions: Physicians who design and/or implement RCTs translate the results of the medical literature more promptly and to a greater extent than physicians in routine clinical practice. Differences between different physician classes need to be studied further amid efforts to reconfigure health care delivery that currently favor more dominant roles for primary care physicians.

AB - Background: Although studies have documented that randomized, controlled trials (RCTs) have a measurable influence on clinical practice, investigators have uncovered important deficiencies in the application of RCT findings to the management of acute myocardial infarction (AMI). Little is known about the extent to which physicians who design and/or implement clinical trials differ from physicians in routine practice in their translation of the literature. Methods: Our aims were to (1) evaluate recent trends in selected treatments of AMI in relation to the publication of RCTs, statistical overviews, and task-force guidelines, and (2) compare prescribing practices in AMI management between physicians in routine clinical practice and physicians who design and/or implement RCTs. We reviewed the use of aspirin, β-blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers on entry and at discharge n patients enrolled in the MILIS, TIM 1, 2, 4, 5, 6, and 9B trials with ST-elevation (and depression in MILIS) myocardial infarction for a period approaching 2 decades (August 1978 to September 1995). We hypothesized that physicians who participate in RCTs apply the findings of the published literature more promptly and thoroughly than physicians in routine practice. Results: Use of aspirin, β-blockers, and angiotensin converting enzyme inhibitors exhibited a statistically significant time-related increase at discharge and, excepting β-blockers, at enrollment across the trials. Prescription of calcium channel blockers showed a statistically significant decrease at discharge only. For all medications under study, increases and earlier and more decreases in use associated with publication of clinical data occurred earlier and more steeply for the discharge cohort (prescriptions by physicians participating in RCTs) than for the enrollment cohort (prescriptions by physicians in routine practice). Recent prescribing practices (1994 to 1995) among RCT investigators and their colleagues have higher concordance with published findings than those of physicians in routine practice. Conclusions: Physicians who design and/or implement RCTs translate the results of the medical literature more promptly and to a greater extent than physicians in routine clinical practice. Differences between different physician classes need to be studied further amid efforts to reconfigure health care delivery that currently favor more dominant roles for primary care physicians.

UR - http://www.scopus.com/inward/record.url?scp=0002099597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0002099597&partnerID=8YFLogxK

U2 - 10.1016/S0002-8703(99)70462-X

DO - 10.1016/S0002-8703(99)70462-X

M3 - Article

VL - 137

SP - 79

EP - 92

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -